key: cord-0551744-q3nv77f8 authors: Rashed, Essam A.; Kodera, Sachiko; Hirata, Akimasa title: COVID-19 Status Forecasting Using New Viral variants and Vaccination Effectiveness Models date: 2022-01-24 journal: nan DOI: nan sha: 480845a2b150894b8e4012c00e699c12471e4350 doc_id: 551744 cord_uid: q3nv77f8 Background: Recently, a high number of daily positive COVID-19 cases have been reported in regions with relatively high vaccination rates; hence, booster vaccination has become necessary. In addition, infections caused by the different variants and correlated factors have not been discussed in depth. With large variabilities and different co-factors, it is difficult to use conventional mathematical models to forecast the incidence of COVID-19. Methods: Machine learning based on long short-term memory was applied to forecasting the time series of new daily positive cases (DPC), serious cases, hospitalized cases, and deaths. Data acquired from regions with high rates of vaccination, such as Israel, were blended with the current data of other regions in Japan to factor in the potential effects of vaccination. The protection provided by symptomatic infection was also considered in terms of the population effectiveness of vaccination as well as the waning protection and ratio and infectivity of viral variants. To represent changes in public behavior, public mobility and interactions through social media were also included in the analysis. Findings: Comparing the observed and estimated new DPC in Tel Aviv, Israel, the parameters characterizing vaccination effectiveness and the waning protection from infection were well estimated; the vaccination effectiveness of the second dose after 5 months and the third dose after two weeks from infection by the delta variant were 0.24 and 0.95, respectively. Using the extracted parameters regarding vaccination effectiveness, new cases in three prefectures of Japan were replicated. The emergence of Coronavirus Disease-2019 (COVID- 19) in late 2019 resulted in several changes in the daily routine of people and has become a significant cause of mortality worldwide, causing more than 5.5 million deaths (https://covid19.who.int). Due to vaccination, the number of daily positive cases (DPC) has decreased in several countries. Although some countries have achieved high vaccination rates, other countries are far behind, with only a small proportion of their respective populations being vaccinated. This is mainly due to the lack of resources 1 , vaccination hesitancy 2 , or other related issues. While mass immunization has been reported in several countries 3 , vaccination rates are not high enough in others. One of the first countries to vaccinate its population was Israel; however, relatively high DPCs were reported in August 2021 despite the country's vaccination rate being above 68% 4 . One reason for this upsurge was attributed to the high interactivity of the Delta variant 5 and the waning protection from vaccination 6 , especially for those who have been vaccinated very early during the pandemic 7 . A similar trend was observed in the United Kingdom 8 and the United States 9 . The data obtained from countries with high vaccination rates would be useful in predicting the future potential in follow-up regions. However, it is difficult to manipulate data acquired from other regions considering the variations of the different influencing factors. Several national and regional projects are currently in progress to predict the status of the COVID-19 pandemic 10, 11 . The aim of such projects is to understand the pandemic data to improve medical resource allocation, intervention, and policy settings. Susceptible, Exposed, Infectious, and Recovered (SIR or SEIR) models have often been used to solve these problems 12, 13 , and several recent studies have demonstrated the robust abilities of machine learning approaches to adjust for realistic scenarios without forming strict assumptions 14 . In contrast, earlier studies did not consider the public's mobility 15 , which has been clarified as a dominant factor characterizing new cases as a surrogate marker for social distancing 16, 17 . In addition, the forecasts were limited to only a few days 18 . Recently, several studies have considered the data pattern change due viral variants, and we have underlined the difficulty of predicting when new variants will appear 19 . It is critical for any successful model to be able to predict the beginning of a new wave of infections and its potential magnitude. The difficulty in modeling the upsurge of cases may also be attributed to behavioral changes when the DPC are low. Although conventional projection strategies did not thoroughly consider the effects of vaccination, some studies did 20 . With the emergence of messenger RNA vaccines, the efficiency of vaccination in protecting against infection will dramatically improve. The weekly incidence of COVID-19 since administering the first vaccine dose started to decrease after two weeks, which further decreased after four weeks 21 . After the second dose, vaccine effectiveness reached 75%-95% after a few weeks 22, 23 . However, vaccine efficiency may depend on the dominant viral variant 22 . For the Pfizer-BioNtech vaccine, its efficacy for health-care workers has been extensively examined 21 and complete vaccination is defined as two doses given 21 days apart. Therefore, data from regions with high vaccination rates and new variants may serve as important guides for forecasting potential risks in other regions. Here, we propose an efficient method to forecast the COVID-19 status of one area based on viral variant modeling and vaccination effectiveness using a framework for data projection obtained from other regions. The proposed approach, which was based on insights and data from regions that have achieved high vaccination rates, can help optimize vaccination requirements in regions with low vaccination rates. Considering that more than 65% of countries still have vaccination rates below 70% (10 Jan. 2022, WHO), these countries may apply protocols from other countries that have achieved high vaccination rates. Moreover, the developed model can provide a clearer understanding of potential booster shot requirements and when they should be administered. The forecasting model was designed using a multi-path long short-term memory (LSTM) neural network based on our earlier study detailed in (19 considered with the updated concurrent data for long term forecasting. In other words, the input network data are updated using the current estimate for future forecasting, as shown in Figure S1 . The projection of the epidemic tendency in one country to other countries is not always successful as epidemic parameters and associated factors in different countries may not be consistent. The two neural networks work well especially during the early stages of vaccination when the effects of vaccination are still unclear. The adaptation model is trained using a simplified combination of data wherein the target must learn the effects of vaccination within different stages of the pandemic. With this design, we can think of the "forecasting model" as the local scope network and the "adaptation model" as the global scope network. This strategy can efficiently enable the use of data of countries with high vaccination rates without considering local features. The data flow between the forecasting and adaptation models is shown in Figure 1 (c). As the vaccination rate may not reflect the actual efficiency due to the variations in vaccines and waning protection over time 7 , we proposed a representation of vaccination protection, which is defined as the vaccination effectiveness at the population level that considers the waning protection. The vaccination effectiveness at the population level in each city or prefecture was assumed to be as follows: where d is the day index and n t denotes the number of people newly administrated with the vaccine t. e t is the individual vaccination effectiveness on i days after inoculation. Parameters a and s are adjusted to reach a vaccination effectiveness peak within K days after inoculation, which then decrease linearly. P is the deemed population expressed as the summation of the population of the entire prefecture and the cumulative number of the second and third doses. Here, we assumed T = 3 to demonstrate the number of vaccine doses (vaccines with a single dose, such as that of Johnson & Johnson, was not considered here) and K = 14 for the two-week latency period of the vaccination effect. The parameters of a 1 and a 2 for the Delta variant were chosen as 0.605 and 0.756, respectively, both of which are based on a meta-analysis of systematic reviews (11 study groups) 22 . The parameters coincide with the reported real-world vaccination effectiveness 24 . The parameters of s and a 3 are computed as explained below. The antibody levels of infected people are comparable to or somewhat lower than those of fully vaccinated persons 25 ; thus, the DPC is counted as additional value of fully vaccinated people. is computed using the following equation: is a weighting parameter assigned to each variant that demonstrates its relative infectivity, and parameters ߙ and ߚ are scaling parameters. As variant data were reported weekly, daily values were computed using linear interpolation. For quantitative evaluation, the average relative error over a period of N days was computed as follows: cases, and deaths were considered in item (i) in addition to items (v) and (vi). In addition, in the analysis of Tokyo, Osaka, and Aichi, the number of tweets and population at night were considered, which are potentially related to changes in public behavior. The effectiveness of the latter can be reported in (27) . The breakdown and definition of each dataset are listed in Table S1 . Vaccination data, along with current COVID-19 data, were collected from external regions (Tel Aviv, Israel). The Social networking data were obtained from Twitter, and mobility at downtown areas were computed as the nighttime population who stayed near restaurants and bars. Twitter data were used as it may indicate social activities where close contact occurs, and the downtown population was considered as several domestic reports have indicated that the main infection clusters may be due to close contacts in these areas. Tweets with keywords "BBQ," "drinking party", and "karaoke" (in Japanese) were chosen as risk-related terms. Data were obtained from NTT Data, The COVID-19 data and vaccination rate in Tel Aviv were obtained from online open sources (https://info.data.gov.il/datagov/home/), and mobility data were obtained from Google mobility reports. The average interval between the administration of the first and second doses was assumed as three weeks. The vaccination effectiveness calculated from Eq. We then explored parameters which will correlate well with the new DPC. The main factors that might potentially influence the DPC in the future are listed in Table S1 . The viral variant is essential and can be extracted from the data in different countries, and the day label of "holiday" is potentially related to behavioral changes; both of which can be easily defined with any uncertainty, thus their use as the default parameters. There are different categories for mobility, including those in different urban regions. In our previous study, we have shown that in most prefectures, mobility at transit stations is an essential parameter, whereas remaining is also related to public activities in different urban regions. In addition, the nighttime population can identify social activities in regions where infection clusters were reported, which we compared using a new set of input parameters. Although weather was suggested to correlate with the number of DPC in some studies, others have denied this 27 . In this study, temperature and humidity, which are also related to the absolute humidity, were considered simultaneously. The vaccination effect was considered in the adaption of the neural network. To demonstrate the effectiveness of our proposed forecasting system, we applied the same scenarios for Tokyo to Osaka and Aichi. Input parameter optimization was then conducted to validate the accuracy of forecasts. The parameters in Eq. (1) were revised to replicate new DPC in Tel Aviv. From Figure 2 Considering the incubation period (7-10 days), the efficiency of vaccination at the population level ranged from 0.29 to 0.32. It is clear from the data presented in Figure 2 (c) that different vaccination models will lead to different estimations of the DPC. After considering all input parameters, an extensive sensitivity study was conducted to minimize the input datasets. First, a single item was selected from each data set to minimize the total forecasting error. The seven selected inputs were then optimized to minimize possible number based on error. It was found that the optimized data inputs are those corresponded to the current DPC, mobility (transit station), model of the viral variant, twitter data ("nomikai"), and vaccination effectiveness. The variant infectivity computed for Tokyo is shown in Figure S2 , with different weighting factors assigned to different viral variants. Figure 3 shows the estimated DPC for the given parameters in Tokyo. The first set was generated using all datasets whereas the second estimation was obtained using optimized data which matched with the most accurate observed values. As shown in Table 1 Figure S3 demonstrates forecasting during a pandemic state wherein positives, serious cases, hospitalized cases, deaths, and hospital dispatch cases for Tokyo, Osaka, and Aichi are forecasted. The estimation of new DPC using the combination of forecasting and adaptation models is shown in Figure 4 . With the forecasting model alone, the spreading phase was highly consistent with real data; however, the decay phase was not. On the other hand, the combination of the two models resulted in more accurate results, especially in the decay phase, due to the application of the vaccination effectiveness acquired from the Tel Aviv data. The difference between the two models in the spread phase was marginal; however, it was significant in the decay phase. This tendency is similar to that of our previous study wherein the adaptation of new viral variants was discussed 19 . We found that different combinations of data as well as different time frames would lead to significant changes in the results, especially those for the long-term forecasting. For example, in the early stages of the pandemic and prior to the emergence of viral variants, the meteorological data was suggested to highly correlate with the incidence of infection 27 . However, when new factors, such as vaccination effectiveness and viral variant infectivity, were considered, the importance of meteorological data was lessened. In the early months of the COVID-19 pandemic, it was possible to estimate the DPC using only a small number of factors; however, after considering large-scale vaccination campaigns and the emergence of different variants, DPC estimation has become complicated. Regarding vaccination effectiveness, the effect of vaccination is not direct; hence, it needs to be carefully modeled by considering the variations in the vaccine type and potential waning of protection. Here, we present a method where the vaccination effect in one country can be projected to another country. For new viral variants, it is crucial to model its infectivity to correctly estimate such that the trigger of new wave and potential peak can be correctly estimated. We studied forecasting using different setoff inputs that demonstrate varied factors discussed in the literature such as public mobility and behavior, meteorological data, vaccination effectiveness, and viral variant infectivity. The results demonstrate that different parameters have different implications along a given time course. Therefore, the training data should be carefully selected to obtain highly accurate long-term forecasts. We presented a feasible method to project the vaccination effectiveness obtained from another country and a model to manage the change in the infectivity of viral variants. As many countries have vaccination rates still below the target threshold for herd immunity set by the World Health Organization, it would be useful to validate the potential risks and forecast future waves of infection using data from other regions with high vaccination rates. No ethical permissions were needed in this study (numerical study with open data). The funders of the study had no role in the study design, data collection, analysis, interpretation, preparation of the manuscript, or decision to publish. Table S1) and (b) optimized datasets (only values of 1-1, 2-4, 5-1, 6-1, 7-1 from Table S1 ) along with true values. Training data are from August 1, 2020 to July 30, 2021. This demonstrates the effect of vaccination, which shows a weak spread phase and prolonged decay phase of the fifth COVID-19 wave. Table S1 ) ** spread (July), peak (August), decay (September), and all wave (July-September) Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment Understanding COVID-19 vaccine hesitancy Developing Covid-19 vaccines at pandemic speed Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine A grim warning from Israel: Vaccination blunts, but does not defeat Delta Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection COVID vaccines protect against Delta, but their effectiveness wanes Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK Breakthrough SARS-CoV-2 infections in 620,000 US Veterans, medRxiv Japanese Cabinet Secretariat. COVID-19 AI & Simulation Project IHME COVID-19 Forecasting Team. Modeling COVID-19 scenarios for the United States SEIR modeling of the COVID-19 and its dynamics A simulation of a COVID-19 epidemic based on a deterministic SEIR model Deep learning methods for forecasting COVID-19 time-Series data: A Comparative study Covid-19 outbreak prediction with machine learning Mobility network models of COVID-19 explain inequities and inform reopening One-Year Lesson: Machine Learning Prediction of COVID-19 Positive Cases with Meteorological Data and Mobility Estimate in Japan Spatio-temporal prediction of the COVID-19 pandemic in US counties: modeling with a deep LSTM neural network Infectivity Upsurge by COVID-19 viral variants in Japan: Evidence from deep learning modeling Stability analysis of SEIR model related to efficiency of vaccines for COVID-19 situation BNT162b2 mRNA Covid-19 vaccine effectiveness among health care workers Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis Effectiveness of BNT162b2 vaccine against delta variant in adolescents Estimating real-world COVID-19 vaccine effectiveness in Israel using aggregated counts Covid-19 breakthrough infections in vaccinated health care workers Announce Phase 3 Trial Data Showing High Efficacy of a Booster Dose of Their COVID-19 Vaccine A systematic review and meta-analysis on correlation of weather with COVID-19